Sandbox ss: Difference between revisions
Jump to navigation
Jump to search
(Created page with "{| |- | valign=top | {| style="margin: 0 0 0em 0em; border: 1px solid #696969; float: left; width:32em" cellpadding="0" cellspacing="0"; ! style="padding: 0 5px; font-size: 10...") |
No edit summary |
||
Line 35: | Line 35: | ||
! style="padding: 0 5px; font-size: 80%; background: #F5F5F5" align=left | ''Preferred Regimen'' | ! style="padding: 0 5px; font-size: 80%; background: #F5F5F5" align=left | ''Preferred Regimen'' | ||
|- | |- | ||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸'''''[[Ceftriaxone]] 2 mg IV q12hx 7 days''''' | | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Ceftriaxone]] 2 mg IV q12hx 7 days''''' | ||
|- | |- | ||
! style="padding: 0 5px; font-size: 80%; background: #F5F5F5" align=left | ▸'''''If Ȕ-Lactam Allergic''''' | ! style="padding: 0 5px; font-size: 80%; background: #F5F5F5" align=left | ▸ '''''If Ȕ-Lactam Allergic''''' | ||
|- | |- | ||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸'''''[[Chloro]] 12.5 mg/kg (up to 1 gm) IV q6h''''' | | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Chloro]] 12.5 mg/kg (up to 1 gm) IV q6h''''' | ||
|- | |- | ||
! style="padding: 0 5px; font-size: 80%; background: #F5F5F5" align=left | ''Alternative Regimen'' | ! style="padding: 0 5px; font-size: 80%; background: #F5F5F5" align=left | ''Alternative Regimen'' | ||
|- | |- | ||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸'''''[[Meropenem]] 2 gm IV q8h''''' <BR>''OR''<BR>'''''[[Moxifloxacin]] 400 mg q24h''''' | | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Meropenem]] 2 gm IV q8h''''' <BR>''OR''<BR>'''''[[Moxifloxacin]] 400 mg q24h''''' | ||
|- | |||
| style="padding: 0 5px; font-size: 100%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B|E. coli, other coliforms, or P. aeruginosa}}'' | |||
|- | |||
! style="padding: 0 5px; font-size: 80%; background: #F5F5F5" align=left | ''Preferred Regimen'' | |||
|- | |||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | '''''[[Ceftazidime]]'''''2 gm IV q8h <BR>''OR''<BR>'''''[[cefepime]] 2 gm IV q8h''''' | |||
|- | |||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ''PLUS OR NOT'' | |||
|- | |||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Gentamicin]]''''' | |||
|- | |||
! style="padding: 0 5px; font-size: 80%; background: #F5F5F5" align=left | ''Alternative Regimen'' | |||
|- | |||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸'''''[[Ciprofloxacin]] 400 mg IV q8–12h'''''<BR>''OR''<BR> '''''[[Meropenem]]R 2 gm IV q8h'''''<BR><BR><BR> | |||
|- | |- | ||
|} | |} | ||
| valign=top | | | valign=top | | ||
{| style="margin: 0 0 0em 0em; border: 1px solid #696969; float: left; width: | {| style="margin: 0 0 0em 0em; border: 1px solid #696969; float: left; width:35em" cellpadding="0" cellspacing="0"; | ||
! style="padding: 0 5px; font-size: 100%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B|S. pneumoniae}}''<sup>‡<sup> | ! style="padding: 0 5px; font-size: 100%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B|S. pneumoniae}}''<sup>‡<sup> | ||
|- | |- | ||
! style="padding: 0 5px; font-size: 80%; background: #F5F5F5" align= | ! style="padding: 0 5px; font-size: 80%; background: #F5F5F5" align=center | ''Pen G MIC <0.1 mcg/mL '' | ||
|- | |- | ||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ ''''' | | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Penicillin]] G 4 million units IV q4h'''''<BR>''OR''<BR>'''''[[Ampicillin]] 2 gm IV | ||
q4h''''' | q4h''''' | ||
|- | |- | ||
! style="padding: 0 5px; font-size: 80%; background: # | ! style="padding: 0 5px; font-size: 80%; background: #DCDCDC" align=left | ''Alternative Regimen'' | ||
|- | |- | ||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸'''''Ceftriaxone 2 gm IV q12h''''' <BR>''OR''<BR> ''''' | | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Ceftriaxone]] 2 gm IV q12h''''' <BR>''OR''<BR> | ||
''''' [[Chloramphenicol]] 1 gm IV q6h''''' | |||
|- | |- | ||
! style="padding: 0 5px; font-size: 80%; background: #F5F5F5" align= | ! style="padding: 0 5px; font-size: 80%; background: #F5F5F5" align=center | ''Pen G MIC :0.1–1 mcg/mL'' | ||
|- | |- | ||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸'''''Ceftriaxone 2 gm IV q12h''''' <BR>''OR''<BR>'''''Cefotaxime 2 gm IV q4–6h''''' | | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Ceftriaxone]] 2 gm IV q12h''''' <BR>''OR''<BR>'''''[[Cefotaxime]] 2 gm IV q4–6h''''' | ||
|- | |- | ||
! style="padding: 0 5px; font-size: 80%; background: # | ! style="padding: 0 5px; font-size: 80%; background: #DCDCDC" align=left | ''Alternative Regimen'' | ||
|- | |- | ||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸'''''Cefepime 2 gm IV q8h'''''<BR>''OR''<BR>''''' | | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Cefepime]] 2 gm IV q8h'''''<BR>''OR''<BR>'''''[[Meropenem]] 2 gm IV q8h''''' | ||
|- | |- | ||
! style="padding: 0 5px; font-size: 80%; background: #F5F5F5" align= | ! style="padding: 0 5px; font-size: 80%; background: #F5F5F5" align=center | ''Pen G MIC :≥2 mcg/mL'' | ||
|- | |- | ||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ ''''' | | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Vancomycin]] 500–750 mg IV q6h''''' | ||
|- | |- | ||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ''PLUS'' | | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ''PLUS'' | ||
|- | |- | ||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸''''' | | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Ceftriaxone]] 2 gm IV q12h''''' <BR>''OR''<BR> '''''[[Cefotaxime]] 2 gm IV q4–6h''''' | ||
|- | |- | ||
! style="padding: 0 5px; font-size: 80%; background: # | ! style="padding: 0 5px; font-size: 80%; background: #DCDCDC" align=left | ''Alternative Regimen'' | ||
|- | |- | ||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸''''' | | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Moxifloxacin]] 400 mg IV q24h''''' | ||
|- | |- | ||
! style="padding: 0 5px; font-size: 80%; background: #F5F5F5" align= | ! style="padding: 0 5px; font-size: 80%; background: #F5F5F5" align=center | ''[[Ceftriaxone]] MIC ≥ 1mcg/mL''''' | ||
|- | |- | ||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ ''''' | | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Vancomycin]] 500–750 mg IV q6h''''' | ||
|- | |- | ||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ''PLUS'' | | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ''PLUS'' | ||
|- | |- | ||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸''''' | | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Ceftriaxone]] 2 gm IV q12h''''' <BR>''OR''<BR> '''''[[Cefotaxime]] 2 gm IV q4–6h''''' | ||
! style="padding: 0 5px; font-size: 80%; background: # | |- | ||
! style="padding: 0 5px; font-size: 80%; background: #DCDCDC" align=left | ''Alternative Regimen'' | |||
|- | |||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Moxifloxacin]] 400 mg IV q24h'''''<BR>'''''If MIC to ceftriaxone >2 mcg/mL, add RIF 600 mg 1x/day''''' | |||
|- | |- | ||
|} | |||
|} | |} |
Latest revision as of 23:44, 14 January 2014
|
|